X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (54) 54
humans (48) 48
male (43) 43
transplantation (43) 43
female (41) 41
adult (39) 39
hematology (39) 39
middle aged (37) 37
aged (32) 32
stem cells (28) 28
oncology (26) 26
leukemia (23) 23
acute myeloid leukemia (21) 21
immunology (19) 19
stem cell transplantation (19) 19
adolescent (18) 18
retrospective studies (18) 18
acute myeloid-leukemia (17) 17
bone-marrow-transplantation (17) 17
young adult (17) 17
hematopoietic stem cells (16) 16
leukemia, myeloid, acute - therapy (16) 16
survival (15) 15
transplants & implants (15) 15
cyclophosphamide (14) 14
hematopoietic stem cell transplantation - methods (14) 14
myelodysplastic syndrome (14) 14
versus-host-disease (14) 14
bone marrow (13) 13
hematologic malignancies (13) 13
treatment outcome (13) 13
cancer (12) 12
mortality (12) 12
aml (11) 11
graft-versus-host reaction (11) 11
patients (11) 11
research (11) 11
survival analysis (11) 11
t cells (11) 11
leukemia, myeloid, acute - immunology (10) 10
multivariate analysis (10) 10
transplantation conditioning - methods (10) 10
transplantation, homologous (10) 10
dendritic cells (9) 9
hematopoietic stem cell transplantation - adverse effects (9) 9
survival rate (9) 9
acute disease (8) 8
child (8) 8
disease-free survival (8) 8
hematology, oncology and palliative medicine (8) 8
immunotherapy (8) 8
lymphocytes t (8) 8
myeloid leukemia (8) 8
outcomes (8) 8
prognosis (8) 8
relapse (8) 8
remission (8) 8
1st complete remission (7) 7
care and treatment (7) 7
chemotherapy (7) 7
dendritic cells - immunology (7) 7
health aspects (7) 7
myelodysplastic syndromes - therapy (7) 7
risk factors (7) 7
stem-cell transplantation (7) 7
unrelated donors (7) 7
adults (6) 6
analysis (6) 6
conditioning regimen (6) 6
follow-up studies (6) 6
hemopoiesis (6) 6
histocompatibility antigen hla (6) 6
life sciences (6) 6
lymphatic leukemia (6) 6
posttransplantation cyclophosphamide (6) 6
recurrence (6) 6
t-lymphocytes - immunology (6) 6
acute lymphatic leukemia (5) 5
age (5) 5
antineoplastic combined chemotherapy protocols - therapeutic use (5) 5
blood (5) 5
child, preschool (5) 5
cytotoxicity, immunologic (5) 5
further section · weitere sektionen (5) 5
hematopoietic stem cell transplantation - mortality (5) 5
leukemia, myeloid, acute - mortality (5) 5
lymphocyte activation (5) 5
lymphocyte transfusion (5) 5
lymphocytes (5) 5
medicine, research & experimental (5) 5
medizin (5) 5
myelodysplastic syndromes - immunology (5) 5
peripheral blood (5) 5
peripheral-blood (5) 5
remission induction (5) 5
t-cells (5) 5
therapy (5) 5
abridged index medicus (4) 4
acute leukemia (4) 4
acute lymphoblastic-leukemia (4) 4
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
British Journal of Haematology, ISSN 0007-1048, 02/2017, Volume 176, Issue 3, pp. 431 - 439
This study analysed the outcome of 267 patients with relapse/refractory acute myeloid leukaemia ( AML ) who received sequential chemotherapy including... 
sequential chemotherapy | reduced intensity conditioning | acute myeloid leukaemia | allogeneic haematopoietic stem cell transplantation | CYTOSINE-ARABINOSIDE | FREE SURVIVAL | BONE-MARROW-TRANSPLANTATION | 1ST COMPLETE REMISSION | MYELODYSPLASTIC SYNDROME | MATCHED UNRELATED DONORS | GRAFT-VERSUS-LEUKEMIA | HIGH-RISK | HLA-IDENTICAL SIBLINGS | HOST-DISEASE | HEMATOLOGY | Recurrence | Humans | Middle Aged | Male | Hematopoietic Stem Cell Transplantation - mortality | Leukemia, Myeloid, Acute - complications | Young Adult | Allografts | Hematopoietic Stem Cell Transplantation - adverse effects | Adult | Female | Surveys and Questionnaires | Retrospective Studies | Transplantation Conditioning - methods | Graft vs Host Disease - etiology | Leukemia, Myeloid, Acute - therapy | Antibodies - therapeutic use | Survival Rate | Treatment Outcome | Combined Modality Therapy | Leukemia, Myeloid, Acute - mortality | Antibodies - administration & dosage | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | T-Lymphocytes - immunology | Aged | Hematopoietic Stem Cell Transplantation - methods | Salvage Therapy - methods | Surveys | Viral antibodies | Chemotherapy | Relapse | Stem cells | Antibodies | Transplantation | T cells | Hematopoietic stem cells | Diseases | Cancer | Graft-versus-host reaction | Immunoglobulins | Transplants & implants | Leukemia | Stem cell transplantation | Transplants | Lymphocytes T | Multivariate analysis | Patients | Survival | Incidence | Cytarabine | Fludarabine | Donors | Conditioning | Index Medicus
Journal Article
Leukemia, ISSN 0887-6924, 01/2019, Volume 33, Issue 1, pp. 230 - 239
Haploidentical stem cell transplantation with T cell-replete grafts and post-transplant cyclophosphamide (PTCy) is increasingly used with encouraging outcome.... 
IMPACT | ONCOLOGY | DONOR | BONE-MARROW-TRANSPLANTATION | GRAFT | ACUTE MYELOID-LEUKEMIA | HEMATOLOGY | HEMATOPOIETIC TRANSPLANTATION | RECONSTITUTION | T-CELLS | CLINICAL-OUTCOMES | BLOOD | Graft vs Host Disease - therapy | Precursor Cell Lymphoblastic Leukemia-Lymphoma - immunology | Prognosis | Follow-Up Studies | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality | Leukemia, Myeloid, Acute - immunology | Hematopoietic Stem Cell Transplantation - mortality | Graft vs Host Disease - immunology | Cyclophosphamide - therapeutic use | Young Adult | Graft vs Host Disease - genetics | Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy | Graft vs Host Disease - mortality | Killer Cells, Natural - immunology | Adult | Female | Retrospective Studies | Leukemia, Myeloid, Acute - therapy | Receptors, KIR - genetics | Survival Rate | Leukemia, Myeloid, Acute - mortality | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Aged | Transplantation Conditioning | Transplantation, Haploidentical | Histocompatibility | Receptors, KIR - immunology | Leukemia, Myeloid, Acute - genetics | Graft-versus-host reaction | Transplants & implants | Leukemia | Stem cell transplantation | Transplantation | Lymphocytes T | Multivariate analysis | Confidence intervals | Lymphocytes | Peripheral blood | Killer cell immunoglobulin-like receptors | Bone marrow | Remission | Natural killer cells | Immunoglobulins | Acute lymphatic leukemia | Myeloid leukemia | Transplants | Lymphatic leukemia | Survival | Patients | Cyclophosphamide | Grafts | Stem cells | Ligands | Acute myeloid leukemia | Index Medicus
Journal Article
Journal Article
Leukemia, ISSN 0887-6924, 02/2019, Volume 33, Issue 2, pp. 508 - 517
Journal Article
Annals of Hematology, ISSN 0939-5555, 03/2019, Volume 98, Issue 3, pp. 753 - 762
In acute myeloid leukemia (AML), primary refractory or relapsed disease, secondary AML, and leukemia with unfavorable genetics are considered high-risk AML... 
AML | FLAMSA-RIC | Haploidentical stem cell transplantation | Sequential conditioning | High-risk AML | Mortality | Transplantation | Stem cells | Transplants & implants | Leukemia | Index Medicus
Journal Article